MeSH D015473 - promyelocytic leukemia acute
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Tretinoin | Tretinoin |  | 1998-06-19 |  |  |
| Arsenic trioxide | Trisenox |  | 2002-03-05 |  |  | |
| Padagis | Tretinoin | Tretinoin |  | 1998-12-24 |  |  |
| Taro Pharmaceutical | Tretinoin | Tretinoin |  | 2019-01-25 |  |  |
| Glenmark Pharmaceuticals | Tretinoin | Tretinoin |  | 2016-12-23 |  |  |
| Ingenus | Arsenic trioxide | Arsenic Trioxide |  | 2018-11-15 |  |  |
| Mylan | Arsenic trioxide | Arsenic trioxide Mylan |  | 2020-04-01 |  |  |
| Tretinoin | Avita |  | 1998-01-29 |  |  | |
| Tretinoin | Tretinoin |  | 2013-07-17 |  |  | |
| Almirall | Tretinoin, Mequinol | Solage |  | 1999-12-10 |  |  |
| Clindamycin, Tretinoin | Veltin |  | 2010-07-16 |  |  | |
| Sandoz | Arsenic trioxide | Arsenic Trioxide |  | 2021-12-02 |  |  |
| Bausch Health Companies | Tretinoin | Renova |  | 1995-12-29 |  |  |
| Tretinoin | Retin-a |  | 1982-01-01 |  |  | |
| Clindamycin, Tretinoin | Ziana |  | 2006-11-07 |  |  | |
| Allergan | Tretinoin | Tretinoin |  | 2010-03-22 |  |  |
| Clindamycin, Tretinoin | Clindamycin Tretinoin |  | 2015-06-12 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
61%14/23
Phase 2
15%6/41
Phase 3
67%8/12
Approved: 2Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use